Selected research
Market Structure
Global 8-Methoxypsoralen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global 8-Methoxypsoralen market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for 8-Methoxypsoralen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for 8-Methoxypsoralen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 8-Methoxypsoralen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for 8-Methoxypsoralen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 8-Methoxypsoralen include Wuxi Sigma Chemical Product, Fisher Scientific, Combi-Blocks, TCI Chemicals, Spectrum-Chemical Products, MP Biomedicals, MedKoo Biosciences, Medical Isotopes and LGM Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global 8-Methoxypsoralen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of 8-Methoxypsoralen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents 8-Methoxypsoralen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 8-Methoxypsoralen market size, projected growth trends, production technologies, key applications, and end-use industries.
8-Methoxypsoralen Segment by Company
Wuxi Sigma Chemical Product
Fisher Scientific
Combi-Blocks
TCI Chemicals
Spectrum-Chemical Products
MP Biomedicals
MedKoo Biosciences
Medical Isotopes
LGM Pharma
BOC Sciences
ApexBio
Alfa Aesar
ALB Technology
AdipoGen
8-Methoxypsoralen Segment by Type
Oral Type
External Use
8-Methoxypsoralen Segment by Application
Antiarrhythmic Drugs
Anti-inflammatory Drugs
Analgesic Drugs
Others
8-Methoxypsoralen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 8-Methoxypsoralen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 8-Methoxypsoralen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 8-Methoxypsoralen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the 8-Methoxypsoralen market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 8-Methoxypsoralen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of 8-Methoxypsoralen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of 8-Methoxypsoralen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Type
- External Use
Applications
- Antiarrhythmic Drugs
- Anti-inflammatory Drugs
- Analgesic Drugs
- Others
Companies covered
- Wuxi Sigma Chemical Product
- Fisher Scientific
- Combi-Blocks
- TCI Chemicals
- Spectrum-Chemical Products
- MP Biomedicals
- MedKoo Biosciences
- Medical Isotopes
- LGM Pharma
- BOC Sciences
- ApexBio
- Alfa Aesar
- ALB Technology
- AdipoGen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global 8-Methoxypsoralen Market Size, 2021 VS 2025 VS 2032
- 1.3 Global 8-Methoxypsoralen Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global 8-Methoxypsoralen Sales Estimates and Forecasts (2021-2032)
- 1.5 Global 8-Methoxypsoralen Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global 8-Methoxypsoralen Market Dynamics
- 2.1 8-Methoxypsoralen Industry Trends
- 2.2 8-Methoxypsoralen Industry Drivers
- 2.3 8-Methoxypsoralen Industry Opportunities and Challenges
- 2.4 8-Methoxypsoralen Industry Restraints
3 8-Methoxypsoralen Market by Manufacturers
- 3.1 Global 8-Methoxypsoralen Revenue by Manufacturers (2021-2026)
- 3.2 Global 8-Methoxypsoralen Sales by Manufacturers (2021-2026)
- 3.3 Global 8-Methoxypsoralen Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global 8-Methoxypsoralen Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 8-Methoxypsoralen Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global 8-Methoxypsoralen Manufacturers, Product Type & Application
- 3.7 Global 8-Methoxypsoralen Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 8-Methoxypsoralen Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 8-Methoxypsoralen Players Market Share by Revenue in 2025
- 3.8.3 2025 8-Methoxypsoralen Tier 1, Tier 2, and Tier 3
4 8-Methoxypsoralen Market by Type
- 4.1 8-Methoxypsoralen Type Introduction
- 4.1.1 Oral Type
- 4.1.2 External Use
- 4.2 Global 8-Methoxypsoralen Sales by Type
- 4.2.1 Global 8-Methoxypsoralen Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global 8-Methoxypsoralen Sales by Type (2021-2032)
- 4.2.3 Global 8-Methoxypsoralen Sales Market Share by Type (2021-2032)
- 4.3 Global 8-Methoxypsoralen Revenue by Type
- 4.3.1 Global 8-Methoxypsoralen Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global 8-Methoxypsoralen Revenue by Type (2021-2032)
- 4.3.3 Global 8-Methoxypsoralen Revenue Market Share by Type (2021-2032)
5 8-Methoxypsoralen Market by Application
- 5.1 8-Methoxypsoralen Application Introduction
- 5.1.1 Antiarrhythmic Drugs
- 5.1.2 Anti-inflammatory Drugs
- 5.1.3 Analgesic Drugs
- 5.1.4 Others
- 5.2 Global 8-Methoxypsoralen Sales by Application
- 5.2.1 Global 8-Methoxypsoralen Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global 8-Methoxypsoralen Sales by Application (2021-2032)
- 5.2.3 Global 8-Methoxypsoralen Sales Market Share by Application (2021-2032)
- 5.3 Global 8-Methoxypsoralen Revenue by Application
- 5.3.1 Global 8-Methoxypsoralen Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global 8-Methoxypsoralen Revenue by Application (2021-2032)
- 5.3.3 Global 8-Methoxypsoralen Revenue Market Share by Application (2021-2032)
6 Global 8-Methoxypsoralen Sales by Region
- 6.1 Global 8-Methoxypsoralen Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global 8-Methoxypsoralen Sales by Region (2021-2032)
- 6.2.1 Global 8-Methoxypsoralen Sales by Region (2021-2026)
- 6.2.2 Global 8-Methoxypsoralen Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America 8-Methoxypsoralen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America 8-Methoxypsoralen Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe 8-Methoxypsoralen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe 8-Methoxypsoralen Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific 8-Methoxypsoralen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific 8-Methoxypsoralen Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa 8-Methoxypsoralen Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa 8-Methoxypsoralen Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global 8-Methoxypsoralen Revenue by Region
- 7.1 Global 8-Methoxypsoralen Revenue by Region
- 7.1.1 Global 8-Methoxypsoralen Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global 8-Methoxypsoralen Revenue by Region (2021-2026)
- 7.1.3 Global 8-Methoxypsoralen Revenue by Region (2027-2032)
- 7.1.4 Global 8-Methoxypsoralen Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America 8-Methoxypsoralen Revenue (2021-2032)
- 7.2.2 North America 8-Methoxypsoralen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe 8-Methoxypsoralen Revenue (2021-2032)
- 7.3.2 Europe 8-Methoxypsoralen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific 8-Methoxypsoralen Revenue (2021-2032)
- 7.4.2 Asia-Pacific 8-Methoxypsoralen Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa 8-Methoxypsoralen Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa 8-Methoxypsoralen Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Wuxi Sigma Chemical Product
- 8.1.1 Wuxi Sigma Chemical Product Company Information
- 8.1.2 Wuxi Sigma Chemical Product Business Overview
- 8.1.3 Wuxi Sigma Chemical Product 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Wuxi Sigma Chemical Product 8-Methoxypsoralen Product Portfolio
- 8.1.5 Wuxi Sigma Chemical Product Recent Developments
- 8.2 Fisher Scientific
- 8.2.1 Fisher Scientific Company Information
- 8.2.2 Fisher Scientific Business Overview
- 8.2.3 Fisher Scientific 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Fisher Scientific 8-Methoxypsoralen Product Portfolio
- 8.2.5 Fisher Scientific Recent Developments
- 8.3 Combi-Blocks
- 8.3.1 Combi-Blocks Company Information
- 8.3.2 Combi-Blocks Business Overview
- 8.3.3 Combi-Blocks 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Combi-Blocks 8-Methoxypsoralen Product Portfolio
- 8.3.5 Combi-Blocks Recent Developments
- 8.4 TCI Chemicals
- 8.4.1 TCI Chemicals Company Information
- 8.4.2 TCI Chemicals Business Overview
- 8.4.3 TCI Chemicals 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 TCI Chemicals 8-Methoxypsoralen Product Portfolio
- 8.4.5 TCI Chemicals Recent Developments
- 8.5 Spectrum-Chemical Products
- 8.5.1 Spectrum-Chemical Products Company Information
- 8.5.2 Spectrum-Chemical Products Business Overview
- 8.5.3 Spectrum-Chemical Products 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Spectrum-Chemical Products 8-Methoxypsoralen Product Portfolio
- 8.5.5 Spectrum-Chemical Products Recent Developments
- 8.6 MP Biomedicals
- 8.6.1 MP Biomedicals Company Information
- 8.6.2 MP Biomedicals Business Overview
- 8.6.3 MP Biomedicals 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 MP Biomedicals 8-Methoxypsoralen Product Portfolio
- 8.6.5 MP Biomedicals Recent Developments
- 8.7 MedKoo Biosciences
- 8.7.1 MedKoo Biosciences Company Information
- 8.7.2 MedKoo Biosciences Business Overview
- 8.7.3 MedKoo Biosciences 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 MedKoo Biosciences 8-Methoxypsoralen Product Portfolio
- 8.7.5 MedKoo Biosciences Recent Developments
- 8.8 Medical Isotopes
- 8.8.1 Medical Isotopes Company Information
- 8.8.2 Medical Isotopes Business Overview
- 8.8.3 Medical Isotopes 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Medical Isotopes 8-Methoxypsoralen Product Portfolio
- 8.8.5 Medical Isotopes Recent Developments
- 8.9 LGM Pharma
- 8.9.1 LGM Pharma Company Information
- 8.9.2 LGM Pharma Business Overview
- 8.9.3 LGM Pharma 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 LGM Pharma 8-Methoxypsoralen Product Portfolio
- 8.9.5 LGM Pharma Recent Developments
- 8.10 BOC Sciences
- 8.10.1 BOC Sciences Company Information
- 8.10.2 BOC Sciences Business Overview
- 8.10.3 BOC Sciences 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 BOC Sciences 8-Methoxypsoralen Product Portfolio
- 8.10.5 BOC Sciences Recent Developments
- 8.11 ApexBio
- 8.11.1 ApexBio Company Information
- 8.11.2 ApexBio Business Overview
- 8.11.3 ApexBio 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 ApexBio 8-Methoxypsoralen Product Portfolio
- 8.11.5 ApexBio Recent Developments
- 8.12 Alfa Aesar
- 8.12.1 Alfa Aesar Company Information
- 8.12.2 Alfa Aesar Business Overview
- 8.12.3 Alfa Aesar 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Alfa Aesar 8-Methoxypsoralen Product Portfolio
- 8.12.5 Alfa Aesar Recent Developments
- 8.13 ALB Technology
- 8.13.1 ALB Technology Company Information
- 8.13.2 ALB Technology Business Overview
- 8.13.3 ALB Technology 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 ALB Technology 8-Methoxypsoralen Product Portfolio
- 8.13.5 ALB Technology Recent Developments
- 8.14 AdipoGen
- 8.14.1 AdipoGen Company Information
- 8.14.2 AdipoGen Business Overview
- 8.14.3 AdipoGen 8-Methoxypsoralen Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 AdipoGen 8-Methoxypsoralen Product Portfolio
- 8.14.5 AdipoGen Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 8-Methoxypsoralen Value Chain Analysis
- 9.1.1 8-Methoxypsoralen Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 8-Methoxypsoralen Production Mode & Process
- 9.2 8-Methoxypsoralen Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 8-Methoxypsoralen Distributors
- 9.2.3 8-Methoxypsoralen Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst